Institutional investors purchased a net $78.4 thousand shares of TXMD during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 56.24% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 7.6 Million shares of TherapeuticsMD Inc
THE DREYFUS CORP. Bought 2.0 Million shares of TherapeuticsMD Inc
THE BOSTON COMPANY ASSET MANAGEM... Bought 919.7 Thousand shares of TherapeuticsMD Inc